BridgeBio Pharma, Inc. · NASDAQ:BBIO

Apuli Maricel sold 2,000 BridgeBio Pharma, Inc. shares (Form 4)

Traded Oct 30, 2026 · Filed Nov 3, 2026

On Oct 30, 2026, Apuli Maricel (Chief Accounting Officer) sold 2,000 BridgeBio Pharma, Inc. shares at US$72.85 for US$146K under a trading plan, leaving 120,687 shares. Filed Nov 3, 2026 (Form 4).

Sold
2,000 shares
Price
US$72.85
Value
US$146K
Holding after
120,687 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Accounting Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 30, 2026Common StockSale2,000US$72.85120,687Direct

Source

Download original · View original at SEC

Related